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Abstract
The major protein of bovine seminal plasma, PDC-109 binds to choline phospholipids present on the sperm plasma
membrane upon ejaculation and plays a crucial role in the subsequent events leading to fertilization. PDC-109 also shares
significant similarities with small heat shock proteins and exhibits chaperone-like activity (CLA). Although the polydisperse
nature of this protein has been shown to be important for its CLA, knowledge of other factors responsible for such an
activity is scarce. Since surface exposure of hydrophobic residues is known to be an important factor which modulates the
CLA of chaperone proteins, in the present study we have probed the surface hydrophobicity of PDC-109 using bisANS and
ANS. Further, effect of phospholipids on the structure and chaperone-like activity of PDC-109 was studied. Presence of
DMPC was found to increase the CLA of PDC-109 significantly, which could be due to the considerable exposure of
hydrophobic regions on the lipid-protein recombinants, which can interact productively with the nonnative structures of
target proteins, resulting in their protection. However, inclusion of DMPG instead of DMPC did not significantly alter the CLA
of PDC-109, which could be due to the lower specificity of PDC-109 for DMPG as compared to DMPC. Cholesterol
incorporation into DMPC membranes led to a decrease in the CLA of PDC-109-lipid recombinants, which could be attributed
to reduced accessibility of hydrophobic surfaces to the substrate protein(s). These results underscore the relevance of
phospholipid binding and hydrophobicity to the chaperone-like activity of PDC-109.
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Introduction
In mammals, the secretions of male accessory glands, testes and
epididymis – collectively termed as seminal plasma – serve to
transport spermatozoa from the male testes to the female uterus,
which leads to fertilization. Seminal plasma is made up of organic
as well as inorganic molecules of low and high molecular weight;
while the low molecular weight fraction contains a wide variety of
chemical species, proteins are the only high molecular weight
constituents present in it [1]. Freshly ejaculated spermatozoa are
unable to fertilize the egg. They acquire fertilizing competence
when they undergo ‘capacitation’, which occurs during their
transit through the female genital tract [2]. The mammalian
seminal plasma contains various proteinaceous decapacitation
factors which prevent inappropriate acrosomal reactions [3] and
inactivation of such factors might modulate the sperm capacitation
in vivo, thereby enhancing the fertilizing capacity of spermatozoa.
Among the various mammalian species, extensive studies have
been carried out on the proteins from bovine seminal plasma. The
bovine seminal plasma contains four acidic proteins designated as
BSP-A1, BSP-A2, BSP-A3 and BSP-30 kDa, which are collec-
tively referred to as bovine seminal plasma proteins or BSP proteins [4–
6]. All BSP proteins have an O-glycosylated N-terminus of variable
length, except BSP-A3 which is not glycosylated [5]. BSP-A1 and
BSP-A2 have identical primary structure and differ only in the
degree of glycosylation, and a mixture of these two proteins is also
referred to as PDC-109 [7,8]. The BSP proteins bind with high
specificity to choline-containing phospholipids such as phospha-
tidylcholine and sphingomyelin present on the sperm plasma
membrane [9]. This binding leads to the extraction of choline
phospholipids and cholesterol from sperm plasma membrane, a
process referred to as cholesterol efflux, which is an important step in
sperm capacitation [10,11].
PDC-109 is a protein with 109 amino acid residues and is made
up of two tandemly repeating fibronectin type-II (FnII)
1 domains
of 38–41 amino acids, each containing two disulfide bridges and
one phosphorylcholine binding site [7,12,13]. Single-crystal X-ray
diffraction studies demonstrated that both the choline-binding sites
are present on the same face of the protein [14]. Binding of PDC-
109 to phospholipid membranes and soluble ligands has been
characterized extensively by biophysical approaches [15–21].
PDC-109 appears to be a multifunctional protein as it has been
reported to bind a variety of other ligands including apolipopro-
teins A1 and A2, heparin, several types of collagens etc [4,6,22].
Very recently we have demonstrated that PDC-109 can
function as a molecular chaperone [23]. The term ‘Molecular
Chaperone’ was originally coined for proteins which prevent the
aggregation of other proteins under conditions of stress and restore
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proteins assist the non-covalent folding/unfolding and the
assembly/disassembly of other proteins, but are not associated
with the latter when they perform their normal biological functions
[32–34]. An important class of molecular chaperones are small
heat shock proteins (sHSP) which exist as large multimeric
structures of 300–1000 kDa in size, with subunits of 12–43 kDa
[35,36]. Most general features of molecular chaperones include
polydispersity, significant surface hydrophobicity and presence of
unordered structural components [35,37,38]. PDC-109 is also a
polydisperse protein and forms oligomeric structures as large as
150 kDa [39]. Polydispersity appears to be essential for the
chaperone-like activity (CLA) of PDC-109, since dissociation of
such large oligomers into smaller ones results in the loss of CLA
[23]. X-ray diffraction studies showed that PDC-109 possesses a
significant amount of unordered structure, whereas CD and FTIR
studies indicate that this protein undergoes conformational
changes upon membrane binding [14,15,39]. Such conformation-
al flexibility may be relevant to the CLA of PDC-109 wherein it
interacts with target proteins to protect them against various types
of stress [23].
Although our earlier studies clearly demonstrated that PDC-109
exhibits chaperone-like activity in vitro [23], how this protein
facilitates the proper folding of the target proteins or prevents their
misfolding/aggregation is not clear. Several studies suggest the
involvement of surface exposed hydrophobic residues on various
chaperones, in their association with partially unfolded proteins
[32–34]. The exposure of hydrophobic regions on the surface of a-
crystallin has been attributed to be responsible for enhanced CLA,
suggesting the role of hydrophobicity in the chaperone like function
of sHSP [32–34]. 4,49-Dianilino-1,19-binaphthyl-5,59-disulphonic
acid (bisANS) and 8-anilinonaphthalene sulphonic acid (ANS) have
been widely used to measure the surface hydrophobicity of various
proteins. Binding of PDC-109 and its domain B to phospholipid
membranes and partialinsertionofsectionsoftheprotein,including
a segment containing Trp93 into the hydrophobic interior of
membranes indicated the presence of hydrophobic stretches in this
protein [16,17,40,41]. In view of this, in the present study we have
investigated the binding of bisANS and ANS with PDC-109 using
isothermal titration calorimetry and steady state fluorescence
spectroscopy, respectively. Further, the effect ANS binding on the
conformation and CLA of PDC-109 was also investigated. Since
PDC-109 binds to phospholipid membranes, it is of interest to study
the possible role of such interactions on the CLA, which was
investigated with a number of target proteins such as alcohol
dehydrogenase (ADH), carbonic anhydrase (CA) and lactate
dehydrogenase (LDH). Presence of dimyristoylphosphatidylcholine
(DMPC)– whichisspecificallyrecognized byPDC-109– resultedin
a multifold increase in the CLA of the protein. ANS and bisANS
binding to DMPC-PDC-109 mixture revealed enhanced exposure
of hydrophobic surfaces, which could be responsible for such a
dramatic change in the CLA. Cholesterol which makes lipid
membranes in the liquid-crystalline phase more rigid was found to
decrease the CLA of PDC-109/DMPC recombinants. Overall, our
present results provide a detailed characterization of the hydro-
phobicity of PDC-109 and demonstrate that phospholipid binding
nature of PDC-109 could also be relevant to its chaperone-like
activity, in vivo.
Materials and Methods
Materials
ANS, bisANS, aldolase, carbonic anhydrase, and DEAE
Sephadex A-25 were from Sigma (St. Louis, MO). Sephadex G-
50 (superfine) was obtained from Pharmacia (Uppsala, Sweden).
DMPC, DMPG and cholesterol were purchased from Avanti
Polar Lipids (Alabster, AL). LDH, ADH, tris base and other
chemicals were purchased from local suppliers and were of the
highest purity available. PDC-109 was purified by a combination
of gel filtration on Sephadex G-50 and affinity chromatography on
DEAE Sephadex A-25 as described earlier [16,42]. The purified
protein was dialyzed extensively against 50 mM Tris buffer,
0.15 M NaCl, 5 mM EDTA, pH 7.4 (TBS-I) and stored at 4uC.
All experiments were performed in TBS-I unless stated otherwise.
Inhibition of thermal aggregation of aldolase by PDC-109
The chaperone-like activity of PDC-109 was assayed by
monitoring its ability to prevent heat-induced aggregation of
aldolase at 48uC [23,27]. Aggregation of aldolase was monitored
by recording light scattering at 360 nm as a function of time using
a PerkinElmer Lambda 35 UV/Vis spectrophotometer, which
was also used for all other aggregation assays reported in this study
as well as for all the absorption measurements. Aldolase (0.93 mM)
was pre-incubated for 5 minutes in the presence and absence of
PDC-109 at room temperature before the assay. Three different
samples with PDC-109:aldolase molar ratios of 1:2.4, 1:1.2 and
1:0.6 were used. Aggregation profile for the native enzyme was
taken as 100% and percent aggregation of other samples was
calculated with respect to that of the native enzyme.
Isothermal titration calorimetric study of bisANS binding
to PDC-109
The binding of bisANS to PDC-109 was studied at 30uCb y
isothermal titration calorimetry (ITC) using a Microcal VP-ITC
instrument (MicroCal LLC, Northampton, MA, USA). In a
typical experiment, 25 aliquots (5 mL each) of 5 mM bisANS were
injected consecutively from the syringe into the calorimeter cell
containing 25 mM PDC-109. To minimize the contribution from
heat of dilution to the measured binding enthalpy, the ligand and
protein solutions were prepared in the same buffer. Injections were
made at intervals of 300 sec, and to ensure proper mixing after
each injection, a constant stirring speed of 300 rpm was
maintained during the experiment. Control experiments were
performed by titrating bisANS into the buffer solution and the
resulting heat changes were subtracted from measured heats of
binding. Solutions were degassed under vacuum prior to their use
in the calorimetric titrations. The titration data were analyzed by
using the sequential binding model available in the Origin software
provided by MicroCal, which yielded the following parameters
associated with the bisANS/PDC-109 interaction: equilibrium
association constant (Ka), enthalpy (DH), entropy (DS) and the
stoichiometry of binding (n, which corresponds to the number of
bisANS molecules bound per molecule of PDC-109).
Fluorescence studies on ANS binding to PDC-109
Binding of ANS to PDC-109 was investigated by fluorescence
titrations monitoring the fluorescence intensity of the probe.
Measurements were performed at 25uC using a Spex Fluoromax-4
spectrofluorimeter with excitation and emission slits of 2 and
10 nm, respectively. Titrations were performed by adding small
aliquots of ANS from a 1 mM stock solution to 2.0 mL of PDC-
109 (OD280>0.05) in the cuvette. Samples were excited at 350 nm
and emission spectra were recorded between 400 and 600 nm. All
the binding data reported here correspond to the average values
obtained from two independent titrations. Fluorescence intensities
were corrected for dilution effects and for fluorescence of free
ligand determined in parallel titrations without the protein.
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chaperone-like activity of PDC-109
A 6.0 mg/ml solution of PDC-109 was incubated with 10 mM
ANS for 30 minutes at ambient temperature. The solution was
passed through a Sephadex G-50 column [(1060.5) cm] to
remove unbound ANS. Protein concentration in the eluted
fractions was determined by Lowry assay [43], whereas the
concentration of bound ANS was estimated using its molar
absorption coefficient of 5610
3 M
21.cm
21 at 350 nm. The effect
of ANS binding on the secondary structures of PDC-109 was
analyzed by CD spectroscopy using a Jasco J-810 spectropolar-
imeter fitted with a thermostatted cell holder and interfaced to a
thermostatic waterbath. Far UV CD spectra were recorded at
25uC using a protein concentration of 0.12 mg/mL at a scan rate
of 50 nm/min using a 2 mm pathlength quartz cell and a slit
width of 2 nm. All spectra were corrected with appropriate buffer
blanks and data are expressed as mean residual ellipticities.
Effect of ANS binding on the CLA of PDC-109 was investigated
by LDH aggregation assay [23]. In a typical experiment 0.15 mg/
mL of LDH was mixed with a fixed concentration (0.05 or
0.075 mg/mL) of native PDC-109 and allowed to stand for 5
minutes at room temperature, followed by incubation at 48uC.
Heat induced aggregation of the enzyme was assessed by
monitoring the increase in sample turbidity at 360 nm as a
function of time. Experiments with ANS bound PDC-109 were
performed at similar concentrations as mentioned above and then
compared with the activity of the native protein. Effect of ANS
alone on the aggregation of the target protein was used as a
positive control. Aggregation of native LDH was taken as 100%
and the aggregation of other samples was normalized with respect
to it.
Phospholipid induced modulation of the CLA and tertiary
structure of PDC-109
Unilamellar vesicles of DMPC and DMPG were used in studies
aimed at investigating the effect of phospholipids on the CLA of
PDC-109. Vesicles were prepared by taking a small amount
(,0.5 mg) of the appropriate phospholipid in a glass test tube,
dissolving it in ca. 100–200 mL of dichloromethane or dichloro-
methane/methanol mixture, followed by evaporation of the
solvent under a continuous stream of nitrogen gas and vacuum
desiccation. The lipid film thus obtained was hydrated with an
appropriate volume of TBS-I to give the desired concentration of
phospholipid (,1 mM) and then subjected to bath sonication (30–
60 minutes), which yielded a transparent solution, indicating the
formation of unilamellar vesicles. To investigate the effect of
phospholipid binding on the protein conformation, PDC-109
(1.0 mg/mL) was incubated with unilamellar vesicles of DMPC or
DMPG (final concentration: 0.1 mM) for 5 minutes and then CD
spectra were recorded at room temperature on a Jasco J-810
spectropolarimeter, essentially as described above.
Chaperone activity was assessed by standard aggregation assays,
where heat induced aggregation of target proteins [LDH, ADH
and carbonic anhydrase (CA)] was monitored as light scattering, as
a function of time. To study the effect of phospholipid binding on
the CLA of PDC-109, individual phospholipids (0–2 mM) were
mixed with a fixed concentration of PDC-109 and allowed to bind
for 5 minutes. LDH was pre-incubated with the appropriate PDC-
109/phospholipid mixture for 5 minutes and then placed in a
spectrophotometer cuvette to record the light scattering of the
solutions. Aggregation of native LDH was taken as 100% and the
aggregation of other samples was normalized with respect to that
of the native enzyme. Concentrations of PDC-109, target proteins
and the lipids as well as the temperature used in different assays
are given in the captions to the figures presenting the results of the
experiments.
BisANS binding to PDC-109, phospholipid vesicles and
PDC-109/phospholipid mixtures
Interaction of bisANS with native PDC-109, phospholipid
vesicles (DMPC or DMPG) and PDC-109/phospholipid mixtures
was investigated at 25uC by steady-state fluorescence spectroscopy.
Unilamellar vesicles of DMPC and DMPG were prepared by bath
sonication as described above. The following samples were
prepared in TBS-I: bisANS; bisANS + PDC-109; bisANS +
DMPC; bisANS + DMPG; bisANS + DMPC + PDC-109; bisANS
+ DMPG + PDC-109. The concentrations of PDC-109,
phospholipid and bisANS in individual samples were fixed at
0.05 mg/mL, 5 mM and ,12 mM, respectively. For the last two
samples, PDC-109 and phospholipid vesicles were mixed and
allowed to stand at room temperature for 10 minutes before the
addition of bisANS. Fluorescence measurements were performed
on a Spex-Fluoromax-4 fluorescence spectrometer. Samples were
excited at 385 nm and emission spectra were recorded between
395 and 650 nm. Slit widths of 3 and 5 nm were used on the
excitation and emission monochromators, respectively.
Effect of cholesterol incorporation into the phospholipid
membrane, on the CLA
Unilamellar vesicles of DMPC and DMPC/cholesterol (4:1,
mol/mol) were prepared by bath sonication as described above.
CA was used as the target protein and the CLA was monitored by
using standard aggregation assays, where heat induced aggrega-
tion of the target protein was recorded as light scattering at
360 nm. In a typical experiment, 0.2 mg/mL of CA was
incubated with a fixed concentration of PDC-109 (0.2 mg/mL)
for 5 minutes at room temperature and the mixture was then
subjected to heat stress by incubating for one hour at 52uC. To
investigate the effect of cholesterol incorporation into DMPC
vesicles on the CLA of PDC-109, mixtures of DMPC and PDC-
109, or DMPC, cholesterol and PDC-109 (containing 5 mM of the
respective phospholipid and 0.2 mg/mL of PDC-109) were pre-
incubated with CA for 5 minutes and then the assay was
performed in a similar way as described above. Aggregation
profiles of the two mixtures were compared in order to assess the
effect of the cholesterol incorporation on the CLA of PDC-109.
Effect of DMPC and DMPC/cholesterol mixture on the
CLA of PDC-109: AFM studies
Carbonic anhydrase was used as a target protein in the AFM
studies aimed at investigating the effect of DMPC or DMPC/
cholesterol on the CLA of PDC-109. Samples of native CA
(0.2 mg/ml) and CA-PDC-109 mixture (1:1 ratio, w/w) were
prepared by incubating them at 52uC in a dry bath for 1 hour. To
probe the effect of DMPC or DMPC/cholesterol binding on the
CLA of PDC-109, a mixture containing CA, PDC-109 and
DMPC (or DMPC/cholesterol; 4:1, mol/mol) was prepared and
incubated at 52uC for 1 hour. Here, PDC-109 was first incubated
with DMPC or DMPC/cholesterol mixture for 5 minutes and
then CA was added to obtain the ternary mixture. The final
concentrations of CA, PDC-109 and DMPC in the above mixture
were 0.2 mg/mL, 0.2 mg/mL and 5 mM, respectively. A 20–
30 mL aliquot of the respective sample was carefully deposited on a
freshly cleaved mica sheet (1 cm61 cm) and allowed to dry for 20–
30 minutes, rinsed with HPLC grade water, dried and transferred
to the AFM stage. Imaging was performed in semi-contact mode
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Moscow, Russia), equipped with a 10.0 mm bottom scanner.
NSG10 cantilevers with Au reflective coating and a nominal
spring constant of 11.8 N/m were used for the scanning. Force
was kept at the lowest possible value by continuously adjusting the
set-point and feed-back gain during imaging.
Results and Discussion
In an earlier study we have demonstrated that PDC-109
exhibits chaperone-like activity and that the polydisperse nature of
PDC-109 is critical for its CLA [23]. However, a knowledge of
other factors that are important for such an activity, or modulate
the CLA, is still lacking. In the present study we have carried out
additional experiments to characterize the CLA of PDC-109 using
two more target proteins, namely aldolase and carbonic
anhydrase. In addition, the effect of phospholipid binding on the
CLA of PDC-109 and the role of hydrophobicity in it were also
investigated.
Chaperone-like activity of PDC-109
Results of turbidimetric studies aimed at investigating the effect
of PDC-109 on the thermal aggregation of aldolase are shown in
Fig. 1A. The results indicate that incubation of aldolase at 48uC
leads to a rapid increase in the sample turbidity initially, which
slows down later on, displaying saturation behavior (curve 1).
Presence of PDC-109 reduced the rate of this aggregation
significantly in a concentration-dependent manner. At a PDC-
109 to aldolase ratio of 1:2.4 the extent of aggregation decreased to
81.4% as compared to that of the native enzyme at the end point
of the assay (curve 2). The aggregation decreased to 37.2% when
the PDC-109 to aldolase ratio was increased to 1:1.2 (curve 3),
whereas just 5% aggregation was observed at a ratio of 1:0.6
(curve 4). A bar diagram showing percent aggregation versus
concentration of PDC-109 is given in Fig. 1B. Qualitatively very
similar results were obtained when carbonic anhydrase was used as
the target protein (Fig. S1). Prevention of heat induced aggregation
of aldolase and CA by PDC-109 lends further support to our
previous report that PDC-109 exhibits chaperone-like activity
against a variety of target proteins [23].
Isothermal titration calorimetric studies on bisANS
binding to PDC-109
ITC measurements to investigate the binding of bisANS to
PDC-109 were carried out at 30uC and a typical ITC profile is
shown in Fig. 2. From this figure it can be seen that the binding
process is endothermic in nature. The titration data could be best
fitted using a sequential binding model, which suggests the presence of
two types of binding interactions between bisANS and PDC-109
(Fig. 2). Thermodynamic parameters obtained from this analysis,
listed in Table 1, indicate that both the interactions are
endothermic in nature with positive changes in enthalpy and
large positive entropic contributions, which compensate for the
unfavorable enthalpy term and yield a net negative value of free
energy (DG). We found that the final values of enthalpy and
entropy associated with each binding site varied somewhat
depending on the input values, although overall both enthalpy
and entropy remained positive irrespective of the input data. Also,
the binding constants did not exhibit much variance. The results
obtained with one of the good fits are summarized in Table 1,
which show that both the binding sites have similar affinity for
bisANS. Variation in the binding parameters depending on the
method used for bisANS interaction with other proteins has also
been reported [44]. The entropy-favored binding of bisANS to
PDC-109 suggests the presence of hydrophobic patches on the
protein surface, which in turn could be useful in its interaction
with the non-native structures of different target proteins, which
prevents their aggregation under stress conditions.
ANS binding to PDC-109 and hydropathy indexing
Fluorescence spectra and binding curve corresponding to the
titration of PDC-109 with ANS are given in Figs. 3A & 3B,
respectively. It is seen from these two figures that addition of ANS
to PDC-109 leads to an increase in the fluorescence intensity of the
probe and the magnitude of the change decreases with increasing
ANS concentration, depicting saturation behavior. In these
experiments, PDC-109 concentration was kept very low in order
to maintain [ANS]bound ,, [ANS]total, such that for further
analysis of the titration data, [ANS]total could be used as a good
approximation of free ligand concentration [45,46]. From the
titration data the association constant for the binding of ANS to
Figure 1. Prevention of thermal aggregation of aldolase by PDC-109. Concentration of aldolase was 0.93 mM in all samples. A) Aggregation
profiles recorded at 48uC are shown for aldolase alone (curve 1), aldolase + 0.39 mM PDC-109 (curve 2), aldolase + 0.78 mM PDC-109 (curve 3) and
aldolase + 1.44 mM PDC-109 (curve 4). B) Bar diagram representing percent aggregation of aldolase (at 900 seconds) under different conditions.
doi:10.1371/journal.pone.0017330.g001
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slope of the Scatchard plot, given in Fig. 3C, the association
constant, Ka was estimated as 3.09610
4 M
21, whereas the X-
intercept of the plot was obtained as 1.2, indicating that each
molecule of PDC-109 has one binding site for ANS, which is
comparable with ANS binding to a-crystallin [47,48].
Hydropathy analysis performed according to Kyte and Doolittle
[49] with a sliding window of 7 residues suggests that the sequence
corresponding to the two FnII domains of PDC-109 is more
hydrophobic than the preceding N-terminal segment (Fig. 3D).
Although this does not necessarily imply that the FnII domains are
directly responsible for the CLA, it is possible that interaction of
apolar residues of these domains with target proteins may be
relevant to the CLA of PDC-109.
Effect of ANS binding on the CLA and secondary
structure of PDC-109
Aggregation assays aimed at investigating the effect of ANS
binding on the CLA of PDC-109 are shown in Fig. 4A. Incubation
of LDH at 48uC results in a rapid increase in the turbidity of the
sample with time in the initial stages, which slows down afterwards
(curve 1). A PDC-109 to LDH ratio (w/w) of 1:3 led to a 5%
reduction in the extent of aggregation at 60 minutes (curve 3),
whereas aggregation decreased further to 50% when the PDC-
109/LDH ratio (w/w) was increased to 1:2 (curve 5). ANS binding
did not lead to any significant change in the CLA at a PDC-109-
ANS:LDH ratio of 1:3 (curve 4), although a slight increase in the
CLA (about 10%) was observed, as compared to native PDC-109,
when the ratio was increased to 1:2 (curve 6). The protein fractions
eluted from the gel filtration column showed a molar ratio of 1:1
for the PDC-109 and bound ANS. ANS alone had a negligible
effect on the aggregation of target protein at the concentrations
mentioned above (curve 2). A bar diagram, indicating the percent
aggregation of LDH under different conditions is shown in Fig. 4B.
Far UV CD spectra, shown in Fig. 4C, indicate that the
secondary structure of PDC-109 in the presence of ANS (dotted
line) is nearly identical to that of the native protein (solid line),
suggesting that ANS binding does not result in any significant
changes in the conformation of the protein. This could be one
reason why ANS binding does not have any noticeable effect on
the CLA of PDC-109. Similar results were observed using ADH as
the target protein and the results obtained are shown in Fig. S2.
Phospholipid induced modulation of the CLA of PDC-109
and alterations in its tertiary structure
Results of aggregation assays to investigate the effect of
phospholipid binding on the CLA of PDC-109 are shown in
Fig. 5. LDH, which is an aggregation-prone enzyme, was used as
the target protein. Upon incubation at 48uC, turbidity of the
sample containing LDH increases rapidly with time initially, but
slows down with further incubation (curve 1, Fig. 5A). In the
presence of PDC-109 at a PDC-109:LDH ratio of 3:4, the extent
of aggregation of LDH decreased to ,29% with respect to that of
the native enzyme (curve 3, Fig. 5A). Pre-incubation of PDC-109
with 0.5 mM DMPC (unilamellar vesicles) resulted in a significant
decrease in the aggregation and at the same PDC-109:LDH ratio,
only 6% aggregation was observed as compared to that of the
native enzyme, whereas no aggregation was seen when PDC-109
was pre-incubated with 2 mM DMPC (curves 4 & 5, Fig. ;5A).
On the other hand, inclusion of DMPG vesicles (0.1 and
0.5 mM) in the solution did not yield any alteration in the CLA
Figure 2. Calorimetric titration of bisANS binding to PDC-109.
Raw data for the titration of bisANS with PDC-109 at 30uC is shown in
the upper panel (A) and the integrated heats of binding obtained from
the raw data are shown in the lower panel (B), after subtracting the
heat of dilution. The solid line in the lower panel represents the best fit
of the experimental data to the sequential binding model in the MicroCal
Origin program. See text for further details.
doi:10.1371/journal.pone.0017330.g002
Table 1. Thermodynamic parameters for the interaction of bisANS with PDC-109.
Binding Site Ka 610
3 (M
21) 2DG kcal.mol
21 DH kcal.mol
21 DS cal.mol
21.K
21
N1 2.5760.1 4.7160.6 7.861.02 41.3
N2 2.5360.07 4.6560.07 101.461.5 350
The values of the parameters were obtained by analyzing the data obtained from isothermal titration calorimetry to a sequential binding model. Values shown
correspond to the averages obtained from two independent titrations and standard deviations are indicated.
doi:10.1371/journal.pone.0017330.t001
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PDC-109 alone and spectra 2–13 were recorded in the presence of increasing concentrations of ANS. B) Binding curve obtained by plotting change in
fluorescence intensity (DF) as function of ANS concentration. C) Linear Scatchard plot for the binding data. Slope of this plot gives association
constant for the interaction and the X-intercept yields the stoichiometry of binding. D) Hydropathy plot of PDC-109 according to Kyte & Doolittle
(1982) using using a 7-residue window. See text for details.
doi:10.1371/journal.pone.0017330.g003
Figure 4. Effect of ANS binding on the CLA and secondary structure of PDC-109. A) Prevention of aggregation of LDH (0.15 mg/ml) by
PDC-109. Aggregation profiles shown correspond to the following samples incubated at 48uC: (1) LDH, (2) LDH + 6 mM ANS, (3) LDH + 0.05 mg/ml
PDC-109, (4) LDH + 0.05 mg/ml (ANS-PDC-109), (5) LDH + 0.075 mg/ml of PDC-109 and (6) LDH + 0.075 mg/ml of (ANS-PDC-109). B) Bar diagram
representing percent aggregation of LDH under different conditions (at 3600 seconds) as shown in (A). C) Far UV CD spectra of PDC-109 in the
absence (solid line) and presence (dotted line) of ANS at room temperature.
doi:10.1371/journal.pone.0017330.g004
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17330Figure 5. Effect of phospholipid binding on the CLA and tertiary structure of PDC-109. A) Effect of DMPC on the prevention of
aggregation of LDH by PDC-109. Aggregation profiles shown correspond to the following samples incubated at 48uC: (1) LDH alone, (2) LDH +2 mMo f
DMPC, (3) LDH + PDC-109, (4) LDH + PDC-109 + DMPC (0.5 mM) and (5) LDH + PDC-109 + DMPC (2 mM). In these experiments LDH and PDC-109 were
used at a concentration of 0.1 and 0.075 mg/ml, respectively. B) Bar diagram representing percent aggregation of LDH for different samples shown in
panel (A) at 3600 seconds. C) Effect of DMPG on the prevention of aggregation of LDH by PDC-109. Aggregation profiles shown correspond to the
following samples incubated at 48uC: (1) LDH alone, (2) LDH + PDC-109 + DMPG (0.1 mM), (3) LDH + PDC-109 + DMPG (0.5 mM), (4) LDH + PDC-109
and (5) LDH + DMPG (0.5 mM). In these experiment LDH and PDC-109 were used at a concentration of 0.12 and 0.05 mg/ml, respectively. D) Bar
diagram for the data shown in (C) at 3600 seconds. E) Near UV CD spectra of PDC-109 under native conditions (solid line), in the presence of DMPC
(dashed line) and DMPG (dotted line).
doi:10.1371/journal.pone.0017330.g005
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PDC-109 alone (curve 4). The concentrations of LDH and PDC-
109 used in this experiment are mentioned in the figure caption
(Fig. 5C). Neither DMPC nor DMPG significantly affected the
aggregation profiles of target protein at the above concentrations
in the absence of PDC-109 (curve 2, Fig. 5A & curve 5, Fig. 5C).
Similar results were obtained in the experiments performed using
CA and ADH as target proteins (see Figs. S1 and S3). Near-UV
CD spectra of PDC-109 obtained in the presence of these two
phospholipids show considerable differences, when compared with
the spectrum of native PDC-109 (Fig. 5E), indicating that the
protein tertiary structure is altered upon phospholipid binding,
which is consistent with earlier reports [15,39].
The dramatic change in the CLA of PDC-109, observed in the
presence of DMPC can be explained in two different ways. One
explanation is that the structural changes in PDC-109, induced by
its interaction with DMPC, can modulate the CLA. Results of our
CD studies are in agreement with this (Fig. 5E). The other
explanation is based on PDC-109 induced partial solubilization of
the vesicles and formation of lipid/protein particles of various
sizes, which could modulate the overall hydrophobicity of the
environment, which may alter the CLA. Our parallel ITC studies
on the binding of PDC-109 to DMPC model membranes showed
that the interaction is characterized by a large positive heat
capacity change (DCp), which suggested that large hydrophobic
surfaces are exposed to water upon binding of PDC-109 to DMPC
membranes [50]. Increase in the hydrophobicity upon interaction
of PDC-109 with DMPC vesicles, was also probed by studying
ANS and bisANS binding as discussed below. As shown above,
another phospholipid, i.e., phosphatidylglycerol, had only a
marginal influence on the CLA of PDC-109 (Fig. 5C), which
could be attributed to the low affinity of its binding to PDC-109 as
compared to phosphatidylcholine.
PDC-109 has been reported to play an important role in
priming spermatozoa for fertilization by a membrane remodeling
process [9] and in a previous report we have demonstrated that
PDC-109 can also function as a molecular chaperone, which could
be of physiological significance during fertilization [23]. The
present results establish a correlation between the membrane
binding and chaperone-like activity of PDC-109, and therefore are
of considerable relevance for the better understanding of the role
of PDC-109 in fertilization.
Enhanced surface hydrophobicity upon interaction of
PDC-109 with phosphatidylcholine membrane
BisANS is a fluorescent probe that is being used extensively for
identifying and characterizing hydrophobic regions of proteins and
other biomolecules. Upon binding to such sites it displays
enhanced fluorescence intensity [51]. Therefore, the extent of
enhancement in its fluorescence intensity could be correlated to
increased exposure of hydrophobic residues or surfaces. Fluores-
cence spectra corresponding to bisANS alone and in the presence
of PDC-109, DMPC, DMPG, and mixtures of PDC-109 with
DMPC and DMPG are shown in Fig. 6A. Fluorescence
enhancement upon bisANS binding to DMPG vesicles (dash-dot
line), was comparable to that of the control sample (buffer +
bisANS, solid thin line), whereas a 11.3-fold enhancement was
observed upon binding to DMPC (dash line), which is comparable
to the fluorescence enhancement observed upon binding to native
PDC-109 (dot line). Fluorescence enhancement upon bisANS
binding to DMPG-PDC-109 mixture was slightly higher than that
observed for binding to native PDC-109 (dash dot dot line),
whereas it was nearly 1.5-fold higher as compared to the
enhancement observed for binding to native PDC-109 and 16.4-
fold higher than control (buffer + bisANS), in the case of DMPC-
PDC-109 complex (solid thick line). A bar diagram indicating the
relative fluorescence intensity of bisANS in various samples is
shown in Fig. 6B.
Dramatic increase in the fluorescence intensity of bisANS, upon
binding to DMPC-PDC-109 mixture indicates increased exposure
of hydrophobic surfaces. Since PDC-109 binds to choline
phospholipids with high affinity, which leads to membrane
Figure 6. Binding of bisANS to phospholipids, PDC-109 and phospholipid-PDC-109 mixtures. (A) Fluorescence spectra shown
correspond to: bisANS in buffer (solid thin line), DMPG (5 mM, dash-dot line), PDC-109 (0.05 mg/ml, dotted line), DMPC (5 mM, dashed line), DMPG-
PDC-109 mixture (dash-dot-dot line) and DMPC-PDC-109 mixture (solid thick line). The final concentration of bisANS in each of the sample is 12.2 mM.
Relative fluorescence intensity of different samples is shown in the form of a bar diagram in panel (B).
doi:10.1371/journal.pone.0017330.g006
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results indicate that these lipid/protein recombinants have a
higher degree of surface hydrophobicity. The increased hydro-
phobicity of these recombinants may be important for their better
interaction with partially unfolded target proteins as compared to
PDC-109 alone and prevention of their aggregation. This
interpretation is consistent with the enhanced chaperone-like
activity of DMPC-PDC-109 mixtures as compared to PDC-109
alone (Figs. 5A, S1A and S3A). PDC-109 has a significantly lower
affinity for phosphatidylglycerol as compared to phosphatidylcho-
line [18,21] and hence its binding to DMPG membranes may not
expose the interior hydrophobic regions of this lipid to the same
extent as is observed upon its binding to DMPC membranes. The
lack of significant change in the fluorescence intensity of bisANS
(dash dot dot line, Figs. 6A) as well as in the CLA of the protein
(Figs. 5C, S1C and S3C) in the presence of DMPG-PDC-109
mixture, are consistent with the above interpretation. Similar
results were obtained for ANS binding to the samples described
above and the results obtained are shown in Fig. S4.
Alteration in the hydrophobicity of PDC-109 upon binding of
PrC was also investigated by ANS binding (Text S1, Fig. S5).
These experiments indicated that PrC binding leads to a
significant decrease in the surface hydrophobicity of the protein
(Text S1). In our earlier study the dramatic decrease in the CLA of
PDC-109 upon PrC binding was attributed to the dissociation of
the polydisperse aggregates of the protein [23]. The present results
indicated that in addition to polydispersity, surface hydrophobicity
is also important for the CLA of PDC-109.
Cholesterol incorporation into phospholipid vesicles
modulates the CLA of PDC-109
As discussed above, incubation of PDC-109 with DMPC
unilamellar vesicles leads to dramatic alteration in the aggrega-
tion behavior of various target proteins (Fig. 5A, S1A and S3A).
In order to investigate the effect of cholesterol, similar
experiments were carried out with samples containing 25 mol%
cholesterol in DMPC unilamellar vesicles and the results obtained
are shown in Fig. 7. Incubation of CA at 52uC results in a rapid
increase in the turbidity which reaches a maximum and slows
down with time (curve 1, Fig. 7A). The extent of aggregation of
CA at the end point of assay (60 minutes) was considered as
100% and the aggregation of other samples was normalized with
respect to this. Prior incubation of CA with PDC-109 led to about
15% reduction in the aggregation (curve 2), whereas pre-
incubation of CA with DMPC-PDC-109 mixture resulted in a
complete inhibition of aggregation (curve 4). However, pre-
incubation with DMPC/cholesterol-PDC-109 mixture resulted in
only 45% inhibition of CA aggregation (curve 3), indicating that
cholesterol incorporation into DMPC vesicles has a negative
impact on the CLA of PDC-109/DMPC recombinants (Figs. 5A,
S1A and S3A). However, it must be noted that DMPC/
cholesterol-PDC-109 recombinants exhibited higher CLA than
PDC-109 alone. Similar results were obtained when LDH was
used as the target protein (see Fig. S6).
Upon binding to phospholipid membranes, PDC-109 removes
lipid molecules from the outer leaflet [10,11,52], leading to
membrane disruption. Our fluorescence studies of bisANS and
ANS binding to DMPC-PDC-109 mixtures suggest that surface
hydrophobicity of the PDC-109/DMPC recombinants is signifi-
cantly higher as compared to that of PDC-109 alone (Figs. 6 and
S4). It is known that the interaction of PDC-109 with membranes
containing phosphatidylcholine membranes results in the forma-
tion of lipid/protein particles with high curvature [16]. In such
highly curved aggregates of lipids, the hydrophobic regions of the
lipids will be more exposed than in normal lipid bilayers. Also,
conformational changes in the protein resulting from lipid binding
[15] may also lead to increased exposure of hydrophobic regions of
the protein. Most probably these additional hydrophobic surfaces
interact with the non-native structures of aggregation prone
proteins, resulting in their protection under stress conditions. On
the other hand, interaction of PDC-109 with DMPC vesicles
containing 25 mol% cholesterol could not extend similar protec-
tion to the target proteins (Figs. 7A and S6). Since cholesterol is
known to provide rigidity to membranes, PDC-109 binding
Figure 7. Effect of cholesterol incorporation into the phospholipid membrane on the CLA of PDC-109. (A) Prevention of aggregation of
CA. Aggregation profiles shown correspond to the following samples incubated at 52uC: (1) CA alone, (2) CA + PDC-109, (3) CA + PDC-109 + DMPC/
cholesterol and (4) CA + PDC-109 + DMPC. Concentrations of both CA and PDC-109 were 0.2 mg/ml in all the samples. B) Bar diagram representing
percent aggregation of CA under different conditions as shown in panel (A) at 3600 seconds.
doi:10.1371/journal.pone.0017330.g007
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This interaction therefore cannot lead to the exposure of the
hydrophobic surfaces to the same extent as is achieved by the
interaction of PDC-109 with membranes containing only
phosphatidylcholine. The CLA of PDC-109 in the presence of
DMPC/cholesterol mixtures is therefore relatively less as com-
pared to that of PDC-109/DMPC recombinants. It is also possible
that direct interaction of cholesterol with the CRAC domain of
PDC-109 may alter the CLA of the protein [53].
Modulation of the CLA of PDC-109 by DMPC or DMPC/
cholesterol mixture: AFM studies
The effect of DMPC or DMPC/cholesterol binding on the CLA
of PDC-109 was also studied using AFM, essentially as described
earlier [23]. AFM images of CA, obtained after incubation at
52uC indicate that this enzyme forms very large aggregates of
several microns in size upon such treatment (Fig. 8A). However,
when CA was incubated at the same temperature in the presence
of PDC-109, considerably smaller aggregates were formed under
Figure 8. AFM studies on the modulation of CLA of PDC-109 by cholesterol incorporation into DMPC membranes. The ability of
cholesterol to modulate the chaperone-like activity of PDC-109/DMPC recombinants was investigated by AFM using carbonic anhydrase as the target
protein. (A) AFM image of CA upon incubation at 52uC (14614 mm). (B) Distribution density histogram for the image shown in (A). (C) AFM image of
CA upon incubation at 52uC in the presence of PDC-109 (565 mm). (D) Distribution density histogram for the image shown in (C). (E) AFM image of
CA upon incubation at 52uC in the presence of DMPC-PDC-109 (666 mm). (F) Distribution density histogram for the image shown in (E). (G) AFM
image of CA upon incubation at 52uC in the presence of DMPC/cholesterol-PDC-109 (14614 mm). (H) Height profile corresponding to the bar shown
in image (G). (I) Distribution density histogram for the image shown in (G).
doi:10.1371/journal.pone.0017330.g008
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a size distribution in the range of 550–650 nm for CA alone (at
52uC), which shifted to 10–60 nm in the presence of PDC-109
(Figs. 8B & D). This shows that although PDC-109 prevents the
aggregation of CA but is not as efficient as it is against LDH and
ADH [23]. Interestingly, PDC-109 pre-incubated with DMPC
prevented the aggregation of CA significantly and the size
distribution was observed to be ,10 nm (Figs. 8E & F). This is
consistent with our turbidimetric studies where inclusion of
DMPC with PDC-109 resulted in multifold enhancement of its
CLA (Figs. 5A, S1A and S3A). On the other hand, pre-incubation
of PDC-109 with DMPC vesicles containing 25 mol% cholesterol
did not prevent the aggregation of CA as efficiently as DMPC
alone (Fig. 8G). As discussed above, the enhanced CLA upon
interaction of PDC-109 with DMPC vesicles appears to be due to
the increased exposure of hydrophobic surfaces upon such
interaction. The presence of a small membrane segment in
Fig. 8G is consistent with the ability of cholesterol to stabilize
choline phospholipid membranes against PDC-109-induced
disruption, due to which the exposure of hydrophobic surfaces is
decreased. This, in turn, would result in a decrease in the CLA of
PDC-109/DMPC recombinants in the presence of cholesterol.
These observations demonstrate that the lipid/protein recombi-
nants, formed by the interaction of PDC-109 with phospholipid
membranes, exhibit higher CLA and prevent the aggregation of
substrate proteins more efficiently than PDC-109 alone. This is
schematically illustrated in Fig. 9.
Conclusions
In summary, our in vitro studies demonstrate that the lipid/protein
complexes formed by the high-affinity binding of PDC-109 to
membranes containing choline phospholipids, exhibit a higher
chaperone-like activity than PDC-109 alone. The lipid/protein
recombinants possess a higher surface hydrophobicity as compared
to native PDC-109, which could be responsible for their better
interaction with partially unfolded proteins and prevention of their
aggregation under stress conditions. Cholesterol incorporation
resulted in a decrease in the CLA of the PDC-109/DMPC
recombinants,which could be attributed tomembrane rigidification,
or to direct interaction of cholesterol with the CRAC domain of
PDC-109.However,theCLAoflipid/proteincomplexeswasalways
higher than that of PDC-109 alone.ANS binding to PDC-109 in the
presence of PrC suggests that in addition to polydispersity,
hydrophobicity is also an important factor for the CLA of PDC-
109. The observation of CLA by PDC-109 in the presence of
phospholipids also mimics the in vivo environment where PDC-109
couldbind totheouterleaflet ofthe spermplasmamembrane,which
makes the experiments of this study physiologically relevant. The
present study could also be important to understand the functional
significance of membrane/protein interaction for the other chaper-
onins suchas spectrin andHsp12 [54,55].Overallour presentresults
shed further light on the CLA of PDC-109 and demonstrate that
hydrophobicity plays an important role in this activity.
Supporting Information
Figure S1 Effect of phospholipid binding on the CLA of
PDC-109. A) Prevention of aggregation of CA (0.2 mg/ml) by
PDC-109. Aggregation profiles of (1) Native CA at 52uC, (2) CA +
0.2 mg/ml PDC-109, (3) CA +5 mM of DMPC, (4) CA + PDC-
109 (0.2 mg/ml) + DMPC (2 mM) and (5) CA + PDC-109
(0.2 mg/ml) + DMPC (5 mM) are shown. B) Bar diagram
representing percent aggregation of CA under different conditions
as shown in (A) at 3600 seconds. C) Aggregation profiles of (1)
Native CA at 52uC, (2) CA + 0.2 mg/ml PDC-109, (3) CA +
Figure 9. A schematic model for the functional role of PDC-109 in sperm capacitation. A) PDC-109 binding induces cholesterol and
choline phospholipids efflux, which is a necessary step for sperm capacitation. Phospholipid membrane (1) and efflux particles made up of PDC-109,
cholesterol and choline phospholipids (2), are shown. B) PDC-109 functions as a molecular chaperone and stabilizes substrate proteins. Substrate
proteins (1), are aggregated under stress conditions (2), which in the presence of PDC-109 (3) or lipid/protein recombinants (4) are stabilized
efficiently.
doi:10.1371/journal.pone.0017330.g009
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(2 mM) are shown. D) Bar diagram for the data shown in (C)a t
3600 seconds.
(TIF)
Figure S2 Effect of ANS binding on the CLA of PDC-109.
Modulation of CLA of PDC-109 by ANS binding was investigated
by aggregation assay with ADH (0.1 mg/mL) as the target protein.
A) Aggregation profiles of (1) ADH at 48uC, (2) ADH + 0.025 mg/
ml PDC-109, (3) ADH + 0.025 mg/ml ANS-PDC-109, (4) ADH +
0.05 mg/ml of PDC-109 and (5) ADH + 0.05 mg/ml of ANS-PDC-
109 are shown. B) Bar diagram representing percent aggregation of
LDH under different conditions as shown in (A) at 960 seconds.
(TIF)
Figure S3 Effect of phospholipid binding on the CLA of
PDC-109. Prevention of aggregation of ADH (0.05 mg/ml) by
PDC-109. A) Aggregation profiles of (1) Native ADH at 48uC, (2)
ADH + 2 mM of DMPC, (3) ADH + PDC-109 (0.025 mg/ml) and
(4) ADH + PDC-109 (0.025 mg/ml) + DMPC (2 mM) are shown.
B) Bar diagram representing percent aggregation of ADH under
different conditions as shown in panel (A) at 960 seconds. C)
Aggregation profiles of (1) Native ADH at 48uC, (2) ADH +
DMPG (0.1 mM), (3) ADH + PDC-109 (0.03 mg/ml), (4) ADH +
PDC-109 (0.03 mg/ml) + DMPG (0.05 mM) and (5) ADH + PDC-
109 (0.03 mg/ml) + DMPG (0.1 mM) are shown. D) Bar diagram
for the data shown in (C) at 900 seconds.
(TIF)
Figure S4 ANS Binding to phospholipids, PDC-109 and
phospholipid-PDC-109 mixtures. A) Fluorescence spectra for
the interaction of ANS with buffer (solid thin line), DMPG (5 mM,
dashdotline),PDC-109(0.05 mg/ml,dot line),DMPC(5 mM,dash
line), DMPG-PDC-109 mixture (dash dot dot line) and DMPC-
PDC-109 mixture (solid thick line) are shown.Final concentration of
ANS in each sample was 50 mM. B) Relative fluorescence intensity
of different samples at the emission maximum.
(TIF)
Figure S5 ANS Binding to PrC and PrC-PDC-109
mixtures. A) Fluorescence spectra of ANS in TBS-1 under
different conditions. 1) with PrC; 2) with PDC-109 + PrC; 3) with
PDC-109. Concentrations of different components used were:
ANS, 50 mM; PDC-109, 0.05 mg/mL; PrC, 10 mM. B) Relative
fluorescence intensity of different samples at the emission
maximum.
(TIF)
Figure S6 The Effect of cholesterol incorporation
into phospholipid membrane, on the CLA of PDC-109.
A) Prevention of aggregation of LDH (0.15 mg/ml). Aggregation
profiles of (1) Native LDH at 50uC, (2) LDH + 0.075 mg/ml PDC-
109, (3) LDH + PDC-109 (0.075 mg/ml) + DMPC/cholesterol
(2 mM) and (4) LDH + PDC-109 (0.075 mg/ml) + DMPC (2 mM)
are shown. B) Bar diagram representing percent aggregation of
LDH under different conditions as shown in (A) at 3600 seconds.
(TIF)
Text S1 Methods and Results. Experimental details em-
ployed for studying the binding of ANS to PDC-109 and PDC-
109/PrC complex and the results obtained from these experiments
are provided.
(DOC)
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